Research ExplorerPublicationsUpdate on bicuspid aortic valve aortopathy

Update on bicuspid aortic valve aortopathy

Standard

Update on bicuspid aortic valve aortopathy. / Girdauskas, Evaldas; Petersen, Johannes.

In: CURR OPIN CARDIOL, Vol. 32, No. 6, 11.2017, p. 651-654.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Girdauskas, E & Petersen, J 2017, 'Update on bicuspid aortic valve aortopathy', CURR OPIN CARDIOL, vol. 32, no. 6, pp. 651-654. https://doi.org/10.1097/HCO.0000000000000456

APA

Girdauskas, E., & Petersen, J. (2017). Update on bicuspid aortic valve aortopathy. CURR OPIN CARDIOL, 32(6), 651-654. https://doi.org/10.1097/HCO.0000000000000456

Vancouver

Girdauskas E, Petersen J. Update on bicuspid aortic valve aortopathy. CURR OPIN CARDIOL. 2017 Nov;32(6):651-654. https://doi.org/10.1097/HCO.0000000000000456

Bibtex

@article{120b2a1cfdd3457e8ed1a4dd2e51601b,
title = "Update on bicuspid aortic valve aortopathy",
abstract = "PURPOSE OF REVIEW: The appropriate treatment of bicuspid aortic valve (BAV)-associated aortopathy is still controversial. We aimed to summarize recent evidence from the literature that focused on the prediction of aortopathy progression and adverse aortic events.RECENT FINDINGS: Following the detailed description of valvulo-aortic phenotypes in BAV disease in the previous imaging studies, the most current research focused on the definition of hemodynamic markers that may affect the progression of BAV-associated aortopathy and search for blood-born biomarkers to improve the prediction of adverse aortic events. Furthermore, genetic analyses are ongoing and some preliminary data will be presented.SUMMARY: Serological biomarkers are a novel and promising diagnostic tool for screening thoracic aortic aneurysmal disease and prediction future adverse aortic events. In combination with rheological imaging as well as traditional risk factors diagnostic accuracy and cost-effectiveness of care in BAV-associated aortopathy will improve significantly. VIDEO ABSTRACT: http://links.lww.com/HCO/A44.",
keywords = "Aortic Diseases/blood, Aortic Valve/abnormalities, Bicuspid Aortic Valve Disease, Biomarkers/blood, Heart Valve Diseases/complications, Humans",
author = "Evaldas Girdauskas and Johannes Petersen",
year = "2017",
month = nov,
doi = "10.1097/HCO.0000000000000456",
language = "English",
volume = "32",
pages = "651--654",
journal = "CURR OPIN CARDIOL",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Update on bicuspid aortic valve aortopathy

AU - Girdauskas, Evaldas

AU - Petersen, Johannes

PY - 2017/11

Y1 - 2017/11

N2 - PURPOSE OF REVIEW: The appropriate treatment of bicuspid aortic valve (BAV)-associated aortopathy is still controversial. We aimed to summarize recent evidence from the literature that focused on the prediction of aortopathy progression and adverse aortic events.RECENT FINDINGS: Following the detailed description of valvulo-aortic phenotypes in BAV disease in the previous imaging studies, the most current research focused on the definition of hemodynamic markers that may affect the progression of BAV-associated aortopathy and search for blood-born biomarkers to improve the prediction of adverse aortic events. Furthermore, genetic analyses are ongoing and some preliminary data will be presented.SUMMARY: Serological biomarkers are a novel and promising diagnostic tool for screening thoracic aortic aneurysmal disease and prediction future adverse aortic events. In combination with rheological imaging as well as traditional risk factors diagnostic accuracy and cost-effectiveness of care in BAV-associated aortopathy will improve significantly. VIDEO ABSTRACT: http://links.lww.com/HCO/A44.

AB - PURPOSE OF REVIEW: The appropriate treatment of bicuspid aortic valve (BAV)-associated aortopathy is still controversial. We aimed to summarize recent evidence from the literature that focused on the prediction of aortopathy progression and adverse aortic events.RECENT FINDINGS: Following the detailed description of valvulo-aortic phenotypes in BAV disease in the previous imaging studies, the most current research focused on the definition of hemodynamic markers that may affect the progression of BAV-associated aortopathy and search for blood-born biomarkers to improve the prediction of adverse aortic events. Furthermore, genetic analyses are ongoing and some preliminary data will be presented.SUMMARY: Serological biomarkers are a novel and promising diagnostic tool for screening thoracic aortic aneurysmal disease and prediction future adverse aortic events. In combination with rheological imaging as well as traditional risk factors diagnostic accuracy and cost-effectiveness of care in BAV-associated aortopathy will improve significantly. VIDEO ABSTRACT: http://links.lww.com/HCO/A44.

KW - Aortic Diseases/blood

KW - Aortic Valve/abnormalities

KW - Bicuspid Aortic Valve Disease

KW - Biomarkers/blood

KW - Heart Valve Diseases/complications

KW - Humans

U2 - 10.1097/HCO.0000000000000456

DO - 10.1097/HCO.0000000000000456

M3 - SCORING: Review article

C2 - 28795978

VL - 32

SP - 651

EP - 654

JO - CURR OPIN CARDIOL

JF - CURR OPIN CARDIOL

SN - 0268-4705

IS - 6

ER -